Ling Gao - Bristol Myers Squibb | 人才画像

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 59 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Protein Arginine Methyltransferase 6 Enhances Immune Checkpoint Blockade Efficacy Via the STING Pathway in MMR-proficient Colorectal Cancer

Jinlin Duan,Tao Chen, Qiwei Li,Yu Zhang,Ting Lu, Junyan Xue,Yang Sun,Ling Gao,Yonglong Zhang

Journal for immunotherapy of cancerno. 3 (2025)

引用0浏览0WOS引用

A Phase I Drug-Drug Interaction Study to Assess the Effect of Futibatinib on P-gp and BCRP Substrates and of P-gp Inhibition on the Pharmacokinetics of Futibatinib

Amanda Long,Ikuo Yamamiya, Michelle Valentine, Ziv Machnes,Nanae Hangai,Bailey Anderson,Volker Wacheck,Ling Gao

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 9 (2024)

引用0浏览0WOS引用

Thermosensitive Methyl-Cellulose-based Injectable Hydrogel Carrying Oxaliplatin for the Treatment of Peritoneal Metastasis in Colorectal Cancer

Ju Yang,Yuanfeng Wei,Ling Gao,Zhaojun Li,Xi Yang

JOURNAL OF MATERIALS CHEMISTRY Bno. 21 (2024): 5171-5180

引用1浏览0WOS引用

Model-based Population Pharmacokinetic and Exposure Response Analyses for Safety and Efficacy of Nivolumab As Adjuvant Treatment in Subjects with Resected Oesophageal or Gastroesophageal Junction Cancer

Yue Zhao, Akihide Tsujimoto,Takafumi Ide,Jenny Zhang, Yan Feng,Ling Gao,Akintunde Bello,Amit Roy

BRITISH JOURNAL OF CLINICAL PHARMACOLOGYno. 11 (2024): 2920-2930

引用0浏览0WOS引用

A Phase I, Open‐label, Single‐dose Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety of Futibatinib

Ling Gao,Ikuo Yamamiya, Mark Pinti, Juan Carlos Rondon,Thomas Marbury,Gareth Tomlinson,Lukas Makris,Nanae Hangai,Volker Wacheck

CTS-CLINICAL AND TRANSLATIONAL SCIENCE（2023）

引用3浏览0WOS引用

Table S2 from Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer

Helena A. Yu,Luis G. Paz-Ares,James Chih-Hsin Yang,Ki Hyeong Lee,Pilar Garrido,Keunchil Park,Joo-Hang Kim,Dae Ho Lee,Huzhang Mao,Sameera R. Wijayawardana,Ling Gao,Rebecca R. Hozak,Bo H. Chao,David Planchard

openalex（2023）

引用0浏览0引用

Abstract CT192: Phase 1, Open-Label, Single-Dose Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety of Futibatinib in Adult Subjects

Ling Gao,Ikuo Yamamiya,Mark Pinti, Juan Carlos Rondon,Thomas Marbury Gareth,Gareth Tomlinson,Lukas Makris,Nanae Hangai,Volker Wacheck

Cancer Researchno. 8_Supplement (2023): CT192-CT192

引用0浏览0引用

Table S3 from Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer

openalex（2023）

引用0浏览0引用

Exposure-response Analysis for Nivolumab Plus Ipilimumab Combination Therapy in Patients with Advanced Hepatocellular Carcinoma (checkmate 040)

Bruno Sangro,Thomas Yau,Anthony B. El-Khoueiry,Masatoshi Kudo,Yun Shen,Marina Tschaika,Amit Roy,Yan Feng,Ling Gao,Urvi Aras

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 8 (2023): 1445-1457

引用6浏览0WOS引用

Optimizing the Dosing Regimen of Cetuximab and Ramucirumab Using the Model-Informed Drug Development Paradigm

Lan Ni, Azhar Zaman Khan,Amanda Long,Ling Gao,Nikki Toms,Elena Gonzalez-Gugel, Susan Holsmer-Brand, Yong Lin,Paolo Abada, Sandra Dickin, Declan O'Dea,Ran Wei,Min-Hua Jen,Himani Aggarwal

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 1 (2023): 77-87

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn